Identification and Validation of Novel Contraction-Regulated Myokines Released from Primary Human Skeletal Muscle Cells

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Raschke, Silja ^a   Eckardt, Kristin ^a   Bjørklund Holven, Kirsten ^b   Jensen, Jørgen ^c   Eckel, Jürgen ^a  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^b UNIVERSITY OF OSLO   (Norway)

^c NORWEGIAN SCHOOL OF SPORT SCIENCES   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; MUSCLE PROTEIN; MYOKINE; PIGMENT EPITHELIUM DERIVED FACTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; MUSCLE CELL; MUSCLE CONTRACTION; MYOTUBE; NORMAL HUMAN; PROTEIN ANALYSIS; PROTEIN SECRETION; REGULATORY MECHANISM; SKELETAL MUSCLE CELL; UNINDEXED SEQUENCE;

ADIPOKINES; ADOLESCENT; ADULT; DIPEPTIDYL PEPTIDASE 4; EYE PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE CELLS; MUSCLE CONTRACTION; MUSCLE PROTEINS; MUSCLE, SKELETAL; NERVE GROWTH FACTORS; PROTEIN ARRAY ANALYSIS; SERPINS; YOUNG ADULT;

EID: 84876535013     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062008     Document Type: Article

References (106)

1. Pedersen BK, (2011) Muscles and their myokines. J Exp Biol 214: 337-346.
2. Holloszy JO, Coyle EF, (1984) Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol 56: 831-838.
3. Ross A, Leveritt M, (2001) Long-term metabolic and skeletal muscle adaptations to short-sprint training: implications for sprint training and tapering. Sports Med 31: 1063-1082.
4. Petersen AM, Pedersen BK, (2005) The anti-inflammatory effect of exercise. J Appl Physiol 98: 1154-1162.
5. Kersten S, Lichtenstein L, Steenbergen E, Mudde K, Hendriks HF, et al. (2009) Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids. Arterioscler Thromb Vasc Biol 29: 969-974.
6. Yang SJ, Hong HC, Choi HY, Yoo HJ, Cho GJ, et al. (2011) Effects of a three-month combined exercise programme on fibroblast growth factor 21 and fetuin-A levels and arterial stiffness in obese women. Clin Endocrinol (Oxf) 75: 464-469.
7. Ostrowski K, Rohde T, Asp S, Schjerling P, Pedersen BK, (1999) Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol 515 (Pt 1): 287-291.
8. Papanicolaou DA, Petrides JS, Tsigos C, Bina S, Kalogeras KT, et al. (1996) Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. Am J Physiol 271: E601-E605.
9. Haugen F, Norheim F, Lian H, Wensaas AJ, Dueland S, et al. (2010) IL-7 is expressed and secreted by human skeletal muscle cells. Am J Physiol Cell Physiol 298: C807-C816.
10. Nielsen AR, Mounier R, Plomgaard P, Mortensen OH, Penkowa M, et al. (2007) Expression of interleukin-15 in human skeletal muscle effect of exercise and muscle fibre type composition. J Physiol 584: 305-312.
11. Broholm C, Mortensen OH, Nielsen S, Akerstrom T, Zankari A, et al. (2008) Exercise induces expression of leukaemia inhibitory factor in human skeletal muscle. J Physiol 586: 2195-2201.
12. Seldin MM, Peterson JM, Byerly MS, Wei Z, Wong GW, (2012) Myonectin (CTRP15), a novel myokine that links skeletal muscle to systemic lipid homeostasis. J Biol Chem 287: 11968-11980.
13. Hittel DS, Axelson M, Sarna N, Shearer J, Huffman KM, et al. (2010) Myostatin decreases with aerobic exercise and associates with insulin resistance. Med Sci Sports Exerc 42: 2023-2029.
14. Hoier B, Olsen K, Nyberg M, Bangsbo J, Hellsten Y, (2010) Contraction-induced secretion of VEGF from skeletal muscle cells is mediated by adenosine. Am J Physiol Heart Circ Physiol 299: H857-H862.
15. Hoier B, Nordsborg N, Andersen S, Jensen L, Nybo L, et al. (2012) Pro- and anti-angiogenic factors in human skeletal muscle in response to acute exercise and training. J Physiol 590: 595-606.
16. Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, et al. (2012) A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481: 463-468.
17. Fischer CP, (2006) Interleukin-6 in acute exercise and training: what is the biological relevance? Exerc Immunol Rev 12: 6-33.
18. Hiscock N, Chan MH, Bisucci T, Darby IA, Febbraio MA, (2004) Skeletal myocytes are a source of interleukin-6 mRNA expression and protein release during contraction: evidence of fiber type specificity. FASEB J 18: 992-994.
19. Carey AL, Steinberg GR, Macaulay SL, Thomas WG, Holmes AG, et al. (2006) Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 55: 2688-2697.
20. van HG, Steensberg A, Sacchetti M, Fischer C, Keller C, et al. (2003) Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 88: 3005-3010.
21. Stelzer I, Zelzer S, Raggam RB, Pruller F, Truschnig-Wilders M, et al. (2012) Link between leptin and interleukin-6 levels in the initial phase of obesity related inflammation. Transl Res 159: 118-124.
22. Piva SJ, Tatsch E, De Carvalho JA, Bochi GV, Kober H, et al. (2013) Assessment of Inflammatory and Oxidative Biomarkers in Obesity and Their Associations with Body Mass Index. Inflammation 36: 226-31.
23. Rotter V, Nagaev I, Smith U, (2003) Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 278: 45777-45784.
24. Senn JJ, Klover PJ, Nowak IA, Mooney RA, (2002) Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51: 3391-3399.
25. Dietze D, Ramrath S, Ritzeler O, Tennagels N, Hauner H, et al. (2004) Inhibitor kappaB kinase is involved in the paracrine crosstalk between human fat and muscle cells. Int J Obes Relat Metab Disord 28: 985-992.
26. Sell H, Eckel J, Dietze-Schroeder D, (2006) Pathways leading to muscle insulin resistance-the muscle-fat connection. Arch Physiol Biochem 112: 105-113.
27. Lehr S, Hartwig S, Lamers D, Famulla S, Muller S, et al. (2012) Identification and validation of novel adipokines released from primary human adipocytes. Mol Cell Proteomics 11: M111.010504.
28. Famulla S, Lamers D, Hartwig S, Passlack W, Horrighs A, et al. (2011) Pigment epithelium-derived factor (PEDF) is one of the most abundant proteins secreted by human adipocytes and induces insulin resistance and inflammatory signaling in muscle and fat cells. Int J Obes (Lond) 35: 762-772.
29. Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, et al. (2011) Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 60: 1917-1925.
30. Yoon JH, Yea K, Kim J, Choi YS, Park S, et al. (2009) Comparative proteomic analysis of the insulin-induced L6 myotube secretome. Proteomics 9: 51-60.
31. Chan CY, Masui O, Krakovska O, Belozerov VE, Voisin S, et al. (2011) Identification of differentially regulated secretome components during skeletal myogenesis. Mol Cell Proteomics 10: M110.004804.
32. Henningsen J, Rigbolt KT, Blagoev B, Pedersen BK, Kratchmarova I, (2010) Dynamics of the skeletal muscle secretome during myoblast differentiation. Mol Cell Proteomics 9: 2482-2496.
33. Hittel DS, Berggren JR, Shearer J, Boyle K, Houmard JA, (2009) Increased secretion and expression of myostatin in skeletal muscle from extremely obese women. Diabetes 58: 30-38.
34. Norheim F, Raastad T, Thiede B, Rustan AC, Drevon CA, et al. (2011) Proteomic identification of secreted proteins from human skeletal muscle cells and expression in response to strength training. Am J Physiol Endocrinol Metab 301: E1013-E1021.
35. Lambernd S, Taube A, Schober A, Platzbecker B, Gorgens SW, et al. (2012) Contractile activity of human skeletal muscle cells prevents insulin resistance by inhibiting pro-inflammatory signalling pathways. Diabetologia 55: 1128-1139.
36. Chan XC, McDermott JC, Siu KW, (2007) Identification of secreted proteins during skeletal muscle development. J Proteome Res 6: 698-710.
37. Yoon JH, Song P, Jang JH, Kim DK, Choi S, et al. (2011) Proteomic analysis of tumor necrosis factor-alpha (TNF-alpha)-induced L6 myotube secretome reveals novel TNF-alpha-dependent myokines in diabetic skeletal muscle. J Proteome Res 10: 5315-5325.
38. Dietze D, Koenen M, Rohrig K, Horikoshi H, Hauner H, et al. (2002) Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes. Diabetes 51: 2369-2376.
39. Sell H, Laurencikiene J, Taube A, Eckardt K, Cramer A, et al. (2009) Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 58: 2731-2740.
40. Klausner RD, Donaldson JG, Lippincott-Schwartz J, (1992) Brefeldin A: insights into the control of membrane traffic and organelle structure. J Cell Biol 116: 1071-1080.
41. Cordero OJ, Salgado FJ, Nogueira M, (2009) On the origin of serum CD26 and its altered concentration in cancer patients. Cancer Immunol Immunother 58: 1723-1747.
42. Staiger H, Haas C, Machann J, Werner R, Weisser M, et al. (2009) Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans. Diabetes 58: 579-589.
43. Catoire M, Mensink M, Boekschoten MV, Hangelbroek R, Muller M, et al. (2012) Pronounced effects of acute endurance exercise on gene expression in resting and exercising human skeletal muscle. PLoS ONE 7: e51066.
44. Barres R, Yan J, Egan B, Treebak JT, Rasmussen M, et al. (2012) Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab 15: 405-411.
45. Broholm C, Laye MJ, Brandt C, Vadalasetty R, Pilegaard H, et al. (2011) LIF is a contraction-induced myokine stimulating human myocyte proliferation. J Appl Physiol 111: 251-259.
46. Ohlendieck K, (2011) Skeletal muscle proteomics: current approaches, technical challenges and emerging techniques. Skelet Muscle 1: 6.
47. De Rossi M, Bernasconi P, Baggi F, de Waal Malefyt R, Mantegazza R, (2000) Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation. Int Immunol 12: 1329-1335.
48. Zhang Z, Cherryholmes G, Mao A, Marek C, Longmate J, et al. (2008) High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis of fibromyalgia. Exp Biol Med (Maywood) 233: 1171-1180.
49. Peterson JM, Pizza FX, (2009) Cytokines derived from cultured skeletal muscle cells after mechanical strain promote neutrophil chemotaxis in vitro. J Appl Physiol 106: 130-137.
50. Vianney JM, Spitsbergen JM, (2011) Cholinergic neurons regulate secretion of glial cell line-derived neurotrophic factor by skeletal muscle cells in culture. Brain Res 1390: 1-9.
51. Nagaraju K, Raben N, Merritt G, Loeffler L, Kirk K, et al. (1998) A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli. Clin Exp Immunol 113: 407-414.
52. Crown AL, He XL, Holly JM, Lightman SL, Stewart CE, (2000) Characterisation of the IGF system in a primary adult human skeletal muscle cell model, and comparison of the effects of insulin and IGF-I on protein metabolism. J Endocrinol 167: 403-415.
53. Borge BA, Kalland KH, Olsen S, Bletsa A, Berggreen E, et al. (2009) Cytokines are produced locally by myocytes in rat skeletal muscle during endotoxemia. Am J Physiol Heart Circ Physiol 296: H735-H744.
54. Horsley V, Jansen KM, Mills ST, Pavlath GK, (2003) IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 113: 483-494.
55. Steensberg A, Keller C, Starkie RL, Osada T, Febbraio MA, et al. (2002) IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle. Am J Physiol Endocrinol Metab 283: E1272-E1278.
56. Bartoccioni E, Michaelis D, Hohlfeld R, (1994) Constitutive and cytokine-induced production of interleukin-6 by human myoblasts. Immunol Lett 42: 135-138.
57. Solberg R, Aas V, Thoresen GH, Kase ET, Drevon CA, et al. (2005) Leptin expression in human primary skeletal muscle cells is reduced during differentiation. J Cell Biochem 96: 89-96.
58. Canto C, Pich S, Paz JC, Sanches R, Martinez V, et al. (2007) Neuregulins increase mitochondrial oxidative capacity and insulin sensitivity in skeletal muscle cells. Diabetes 56: 2185-2193.
59. Uaesoontrachoon K, Yoo HJ, Tudor EM, Pike RN, Mackie EJ, et al. (2008) Osteopontin and skeletal muscle myoblasts: association with muscle regeneration and regulation of myoblast function in vitro. Int J Biochem Cell Biol 40: 2303-2314.
60. Sejersen T, Betsholtz C, Sjolund M, Heldin CH, Westermark B, et al. (1986) Rat skeletal myoblasts and arterial smooth muscle cells express the gene for the A chain but not the gene for the B chain (c-sis) of platelet-derived growth factor (PDGF) and produce a PDGF-like protein. Proc Natl Acad Sci U S A 83: 6844-6848.
61. Lappas M, Yee K, Permezel M, Rice GE, (2005) Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies. J Endocrinol 186: 457-465.
62. Yu HC, Wu TC, Chen MR, Liu SW, Chen JH, et al. (2010) Mechanical stretching induces osteoprotegerin in differentiating C2C12 precursor cells through noncanonical Wnt pathways. J Bone Miner Res 25: 1128-1137.
63. Jensen L, Schjerling P, Hellsten Y, (2004) Regulation of VEGF and bFGF mRNA expression and other proliferative compounds in skeletal muscle cells. Angiogenesis 7: 255-267.
64. Perez-Ilzarbe M, Agbulut O, Pelacho B, Ciorba C, San Jose-Eneriz E, et al. (2008) Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium. Eur J Heart Fail 10: 1065-1072.
65. Chevrel G, Page G, Granet C, Streichenberger N, Varennes A, et al. (2003) Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis. J Neuroimmunol 137: 125-133.
66. Tournadre A, Lenief V, Miossec P, (2010) Expression of Toll-like receptor 3 and Toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by Th1 and Th17 cytokines. Arthritis Rheum 62: 2144-2151.
67. Bortoluzzi S, Scannapieco P, Cestaro A, Danieli GA, Schiaffino S, (2006) Computational reconstruction of the human skeletal muscle secretome. Proteins 62: 776-792.
68. Matthews VB, Astrom MB, Chan MH, Bruce CR, Krabbe KS, et al. (2012) Erratum to: Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase. Diabetologia 55: 864.
69. Matthews VB, Astrom MB, Chan MH, Bruce CR, Krabbe KS, et al. (2009) Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase. Diabetologia 52: 1409-1418.
70. Porter JD, Guo W, Merriam AP, Khanna S, Cheng G, et al. (2003) Persistent over-expression of specific CC class chemokines correlates with macrophage and T-cell recruitment in mdx skeletal muscle. Neuromuscul Disord 13: 223-235.
71. Cheng M, Nguyen MH, Fantuzzi G, Koh TJ, (2008) Endogenous interferon-gamma is required for efficient skeletal muscle regeneration. Am J Physiol Cell Physiol 294: C1183-C1191.
72. Alvarez B, Quinn LS, Busquets S, Lopez-Soriano FJ, Argiles JM, (2002) TNF-alpha modulates cytokine and cytokine receptors in C2C12 myotubes. Cancer Lett 175: 181-185.
73. Fernyhough P, Diemel LT, Tomlinson DR, (1998) Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats. Diabetologia 41: 300-306.
74. Funakoshi H, Belluardo N, Arenas E, Yamamoto Y, Casabona A, et al. (1995) Muscle-derived neurotrophin-4 as an activity-dependent trophic signal for adult motor neurons. Science 268: 1495-1499.
75. Joory KD, Levick JR, Mortimer PS, Bates DO, (2006) Vascular endothelial growth factor-C (VEGF-C) expression in normal human tissues. Lymphat Res Biol 4: 73-82.
76. Kivela R, Havas E, Vihko V, (2007) Localisation of lymphatic vessels and vascular endothelial growth factors-C and-D in human and mouse skeletal muscle with immunohistochemistry. Histochem Cell Biol 127: 31-40.
77. Hojman P, Dethlefsen C, Brandt C, Hansen J, Pedersen L, et al. (2011) Exercise-induced muscle-derived cytokines inhibit mammary cancer cell growth. Am J Physiol Endocrinol Metab 301: E504-E510.
78. Cordero OJ, Salgado FJ, Nogueira M, (2009) On the origin of serum CD26 and its altered concentration in cancer patients. Cancer Immunol Immunother 58: 1723-1747.
79. Becerra SP, (1997) Structure-function studies on PEDF. A noninhibitory serpin with neurotrophic activity. Adv Exp Med Biol 425: 223-237.
80. Tombran-Tink J, Chader GG, Johnson LV, (1991) PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res 53: 411-414.
81. Steele FR, Chader GJ, Johnson LV, Tombran-Tink J, (1993) Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci U S A 90: 1526-1530.
82. Yamagishi S, Adachi H, Abe A, Yashiro T, Enomoto M, et al. (2006) Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome. J Clin Endocrinol Metab 91: 2447-2450.
83. Jenkins A, Zhang SX, Gosmanova A, Aston C, Dashti A, et al. (2008) Increased serum pigment epithelium derived factor levels in Type 2 diabetes patients. Diabetes Res Clin Pract 82: e5-e7.
84. Gattu AK, Birkenfeld AL, Jornayvaz F, Dziura J, Li F, et al. (2012) Insulin resistance is associated with elevated serum pigment epithelium-derived factor (PEDF) levels in morbidly obese patients. Acta Diabetol 49: S161-9.
85. Sabater M, Moreno-Navarrete JM, Ortega FJ, Pardo G, Salvador J, et al. (2010) Circulating pigment epithelium-derived factor levels are associated with insulin resistance and decrease after weight loss. J Clin Endocrinol Metab 95: 4720-4728.
86. Oberbach A, Bluher M, Wirth H, Till H, Kovacs P, et al. (2011) Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes. J Proteome Res 10: 4769-4788.
87. Nikolic N, Bakke SS, Kase ET, Rudberg I, Flo H, et al. (2012) Electrical pulse stimulation of cultured human skeletal muscle cells as an in vitro model of exercise. PLoS ONE 7: e33203.
88. Wu C, Orozco C, Boyer J, Leglise M, Goodale J, et al. (2009) BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 10: R130.
89. Mentlein R, Gallwitz B, Schmidt WE, (1993) Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem 214: 829-835.
90. Marguet D, Baggio L, Kobayashi T, Bernard AM, Pierres M, et al. (2000) Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26. Proc Natl Acad Sci U S A 97: 6874-6879.
91. Baetta R, Corsini A, (2011) Pharmacology of dipeptidyl peptidase-4 inhibitors: similarities and differences. Drugs 71: 1441-1467.
92. Pedersen BK, Fischer CP, (2007) Beneficial health effects of exercise-the role of IL-6 as a myokine. Trends Pharmacol Sci 28: 152-156.
93. Baggiolini M, Dewald B, Moser B, (1994) Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 55: 97-179.
94. Qin S, LaRosa G, Campbell JJ, Smith-Heath H, Kassam N, et al. (1996) Expression of monocyte chemoattractant protein-1 and interleukin-8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential. Eur J Immunol 26: 640-647.
95. Christiansen T, Richelsen B, Bruun JM, (2005) Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes (Lond) 29: 146-150.
96. Bruun JM, Lihn AS, Pedersen SB, Richelsen B, (2005) Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab 90: 2282-2289.
97. Sell H, Eckel J, (2007) Monocyte chemotactic protein-1 and its role in insulin resistance. Curr Opin Lipidol 18: 258-262.
98. Hubal MJ, Chen TC, Thompson PD, Clarkson PM, (2008) Inflammatory gene changes associated with the repeated-bout effect. Am J Physiol Regul Integr Comp Physiol 294: R1628-R1637.
99. Garcia JJ, Bote E, Hinchado MD, Ortega E, (2011) A single session of intense exercise improves the inflammatory response in healthy sedentary women. J Physiol Biochem 67: 87-94.
100. Moller N, Jorgensen JO, (2009) Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 30: 152-177.
101. Birzniece V, Nelson AE, Ho KK, (2011) Growth hormone and physical performance. Trends Endocrinol Metab 22: 171-178.
102. Frost RA, Nystrom GJ, Lang CH, (2002) Regulation of IGF-I mRNA and Signal Transducers and Activators of Transcription-3 and-5 (Stat-3 and-5) by GH in C2C12 Myoblasts. Endocrinology 143: 492-503.
103. Ge X, Yu J, Jiang H, (2012) Growth hormone stimulates protein synthesis in bovine skeletal muscle cells without altering insulin-like growth factor-I mRNA expression. J Anim Sci 90: 1126-1133.
104. Sotiropoulos A, Ohanna M, Kedzia C, Menon RK, Kopchick JJ, et al. (2006) Growth hormone promotes skeletal muscle cell fusion independent of insulin-like growth factor 1 up-regulation. Proc Natl Acad Sci U S A 103: 7315-7320.
105. Bolton K, Segal D, McMillan J, Jowett J, Heilbronn L, et al. (2008) Decorin is a secreted protein associated with obesity and type 2 diabetes. Int J Obes (Lond) 32: 1113-1121.
106. Garg MK, Dutta MK, Mahalle N, (2012) Adipokines (adiponectin and plasminogen activator inhhibitor-1) in metabolic syndrome. Indian J Endocrinol Metab 16: 116-123.